NeoGenomics names Carolyn Starrett to its Board
NeoGenomics appointed Carolyn Starrett to its Board of Directors. Her experience in oncology data and AI strengthens the company's leadership for precision medicine growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day